Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation
This study compared two main different induction protocols used to treat myeloma eligible patients in Brazil. VCD against CTD.
Multiple Myeloma|Effects of Chemotherapy
DRUG: Bortezomib, cyclophosphamide, thalidomide, dexamethasone
Response rate better than very good partial response after 4 induction cycles, The primary outcome is to observe the difference response rate between VCD and CTD induction myeloma elegible patient, Response rate after induction phase - at the end of cycle 4- (28 days each cycle)- time frame trough study completion
The primary aim was observe response rate after 4 induction cycles.